|
|
Diane Krause, Lloyd G. Cantley
J Clin Invest. 2005;
115(7):1705
doi:10.1172/JCI25540
Abstract |
Full text
| PDF

E
pithelial organs such as the intestine and skin have a relatively high rate of cell loss and thus require a reservoir of stem cells capable of both replacing the lost epithelia and maintaining the reservoir. Whether the kidney has such a stem cell niche has been a subject of great interest; the majority of data suggest that replacement of renal epithelial cells occurs via dedifferentiation and proliferation of existing tubular cells, while some studies demonstrate the presence of potential tubular stem cells in the renal interstitium. However, recent reports have suggested that the bone marrow may also be a source of stem cells for tubule turnover and/or repair. In this issue of the JCI, 2 groups explore the role of endogenous cells versus bone marrow–derived cells in mediating tubule repair. Duffield and colleagues demonstrate that bone marrow does contain cells capable of protecting the kidney from ischemic injury, but found that these cells do not act by direct incorporation into the repaired tubular segments. In contrast, Lin and coworkers found that some bone marrow–derived cells do appear to incorporate into the injured tubule as epithelial cells (see the related article beginning on page 1756). Importantly, both groups conclude that the majority of tubule repair occurs via proliferation of endogenous renal cells rather than incorporation of bone marrow–derived cells.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(35)
| Title and authors |
Publication |
Year |
From kidney development to drug delivery and tissue engineering strategies in renal regenerative medicine
Patricia Y.W. Dankers, Jasper M. Boomker, E.W. Meijer, Eliane R. Popa, Marja J.A. van Luyn
|
Journal of Controlled Release
|
2011 |
Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks
Uta Kunter, Song Rong, Marcus J Moeller, Jürgen Floege
|
Kidney Int Supp
|
2011 |
Stem cells and the repair of radiation-induced salivary gland damage
RP Coppes, MA Stokman
|
Oral Diseases
|
2011 |
Proliferative capacity of stem/progenitor-like cells in the kidney may associate with the outcome of patients with acute tubular necrosis
Youxin Ye, Bingyin Wang, Xinxin Jiang, Weiming Hu, Jian Feng, Hua Li, Mei Jin, Yingjuan Ying, Wenjuan Wang, XiaoOu Mao, Kunlin Jin
|
Human Pathology
|
2011 |
Is secondary hyperparathyroidism-related myelofibrosis a negative prognostic factor for kidney transplant outcome?
Maurizio Bellavia, Maria Concetta Gioviale, Giuseppe Damiano, Vincenzo Davide Palumbo, Francesco Cacciabaudo, Roberta Altomare, Giuseppe Buscemi, Attilio Ignazio Lo Monte
|
Medical Hypotheses
|
2011 |
Kidney repair and stem cells: a complex and controversial process
Brian A. Yeagy, Stephanie Cherqui
|
Pediatr Nephrol
|
2011 |
Paracrine Interaction between Bone Marrow-derived Stem Cells and Renal Epithelial Cells
Rafael S. Lindoso, Dayana S. Araujo, Juliana Adão-Novaes, Rafael M. Mariante, Karine S. Verdoorn, Lucianne Fragel-Madeira, Celso Caruso-Neves, Rafael Linden, Adalberto Vieyra, Marcelo Einicker-Lamas
|
Cell Physiol Biochem
|
2011 |
Mesenchymal Stem Cells
Benjamin D. Humphreys, Joseph V. Bonventre
|
Regenerative Nephrology
|
2011 |
Treatment of Acute Kidney Injury with Allogeneic Mesenchymal Stem Cells: Preclinical and Initial Clinical Data
Florian E. Tögel, Christof Westenfelder
|
Regenerative Nephrology
|
2011 |
Potential Risks of Stem Cell Therapies
Uta Kunter, Jürgen Floege
|
Regenerative Nephrology
|
2011 |
|